Nattokinase is an enzyme found in nature that is formed by fermenting soybeans to produce natto, a Japanese food. The enzyme is a serine protease with fibrinolytic properties; this means that it has the ability to degrade certain proteins that contribute to the formation of blood clots. Based on these properties, nattokinase has been researched for many years in the areas of cardiology as well as blood pressure.
During the COVID-19 pandemic, interest in nattokinase research increased. Researchers started looking into the possibility of its proteolytic activity interacting with SARS-CoV-2 proteins, including the spike protein that is crucial in viral attachment and cell entrance. According to a 2022 lab study, nattokinase decreased the amount of spike protein found on the surface of experimentally treated cells under laboratory conditions.
Discussions about nattokinase and spike protein, including issues with fibrinolysis, inflammation, microclots, and Long COVID, have benefited from these discoveries. Laboratory results, however, should not be taken as evidence of a human clinical therapy impact. This page summarises recent research on nattokinase spike proteins, suggested mechanisms, and significant limitations.
Nattokinaseis an enzyme produced during the fermentation of soybeans to makenatto, a traditional Japanese food. It has attracted scientific interest because of its biological activity and potential effects on cardiovascular and circulatory health. Researchers continue to studynattokinaseto better understand its properties andpossible applications.
Nattokinase originates from natto, a fermented soybean food traditionally consumed in Japan. During fermentation, Bacillus subtilisnat to produces several enzymes, including nattokinase.
Nattokinase is naturally produced when soybeans undergo fermentation with Bacillus subtilis natto. Commercial nattokinase supplements are typically produced through controlled fermentation and then processed and standardized for use in dietary supplement formulations.
Natto has been consumed in Japan for centuries as a traditional fermented food. It is valued as a source of nutrients and naturally occurring compounds produced during fermentation, including enzymes such as nattokinase.
Researchers study nattokinase because of its fibrinolytic and other biological activities observed in laboratory and clinical research. Studies have explored its potential relationship with blood clotting, circulation, and cardiovascular health. Research is ongoing, and nattokinase should not be considered a proven treatment for any disease or medical condition.
This is where you summarize the studies.
Proteolytic activity and fibrinolytic activity are two characteristics of nattokinasethat are relevant to current study, which is why researchers are interested in it. In a laboratory environment, nattokinase, a protease, may break down certain proteins. In a 2022 study, researchers focused on its capacity to break down spike protein, observingdose and time dependent spike protein degradation in laboratory conditions.
Prior research on nattokinase was not so much concerned with spike protein as it was with blood pressure, coagulation, fibrinolysis, and cardiovascular health. After taking supplements for eight weeks, the systolic and diastolic blood pressure of persons with high blood pressure decreased somewhat in a randomised controlled experiment.
Coagulation, fibrin, inflammation, and potential microclot formation problems have all been studied independently by Long COVID researchers. While some researchers have questioned how these findings should be characterised and interpreted, others have found fibrin-containing or amyloid-like particles in blood samples from individuals with Long COVID. These fields of study resulted in hypotheses linking the fibrinolytic and enzymatic characteristics of nattokinase with spike protein and post-COVID studies.
Numerous methods thatnattokinasemay interact with proteins, fibrin,microclots, and inflammatory pathways have been suggested by researchers.
The proteolytic activity of nattokinase is one of the most often mentioned mechanisms. In the 2022 Molecules study, scientists subjected cell lysates that expressed spike proteins to nattokinase and saw the spike protein degrade. Additionally, they noted that the surface of experimentally transfected cells had less spike protein.
Importantly, this was not a human clinical trial but rather a laboratory study. In order to show that nattokinase may not just operate on spike protein, the researchers also saw the degradation of other proteins, such as ACE2 and GAPDH. Consequently, the findings cannot prove that nattokinase taken orally eliminates spike protein from the human body.
The effects of nattokinase on fibrinolysis, the body's mechanism for dissolving fibrin in blood clots, have long been researched. One reason nattokinase has been explored in cardiovascular research is this feature. Nattokinase supplementation was linked to lower blood pressure, according to a recent systematic review and meta-analysis of randomised controlled tests, however the included studies' limitations and results differed.
However, at the same time, an experiment conducted randomly for a period of three years with 265 patientsindicatedthat there was no influence ofnattokinaseon the blood pressure, lab results, or the progression of subclinical atherosclerosis as compared to a placebo. This is thereason whyspecific research onnattokinaseneeds to be considered in scientific literature.
The scientific debate around Long COVID now include smicroclot studies. According to some research, samples from individuals with Long COVID show persistent fibrin-related microclots or amyloid-like formations, and it has been suggested that some symptoms may be caused by impaired fibrinolysis.
Researchers and some medical professionals have suggested that nattokinase may be relevant to this field of study due to its fibrinolytic action. However, there is currently little proof that nattokinase safely and successfully removes Long COVID-associated microclots in patients. Additional controlled clinical research is required.
Coagulation and inflammatory processes may interact, especially during and following viral diseases. Inflammatory chemicals, platelet activation, fibrin-related anomalies, and other biological processes have all been examined in relation to long COVID.
Due to its proteolytic and fibrinolytic characteristics, researchers have suggested that nattokinase may be related to some of these processes. However, more research is needed to determine the exact connection between nattokinase, inflammation, and spike protein
Rather than clear clinical data, the main source of interest in nattokinase long covid is overlapping study topics. Inflammation, endothelial dysfunction, fibrin-related particles, coagulation problems, and other pathways have all been explored by some medical professionals and researchers as potential causes of persistent symptoms in specific patients.
The use of nattokinase, bromelain, and curcumin was recommended in a clinical-oriented research work to alleviate post-acute symptoms, although the researchers called for large-scale, prospective, randomized, double-blind, and placebo-controlled trials to identify the strengths and weaknesses of the method.
However, there is no proof that taking nattokinase supplements helps to cure Long COVID, clear spike protein from the body or reverse post-COVID symptoms, despite the fact that its effects on proteins and fibrinolysis have been proven experimentally. The area of microclot research itself is still developing, with ongoing discussions concerning terminology, processes, diagnostic techniques, and therapy implications.
Explore more studies and scientific papers related to nattokinase.
Molecules
Molecules
Molecules
From decades of interest in fibrinolysis and cardiovascular health, nattokinase research has evolved into more recent studies including Long COVID and SARS-CoV-2 spike protein. While independent research has looked at fibrin-related problems and inflammation in Long COVID, laboratory tests have drawn attention by finding spike-protein degradation under laboratory conditions. Lab tests are not an indication that nattokinase deactivates the spike protein or cures Long COVID since the research is still in progress.
To prove the effectiveness of the supplement, its optimal application, safety and significance, further studies among people are required. The ones who are interested in studies of nattokinase spike proteins need to look through scientific sources and address a professional medical doctor before taking any supplements, especially in connection with medications.
